Call for Abstract
Scientific Program
3rd Global Summit on Oncology and Hematology, will be organized around the theme “”
oncologyresearch 2022 is comprised of 15 tracks and 0 sessions designed to offer comprehensive sessions that address current issues in oncologyresearch 2022.
Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
Cancer Stem Cell (CSC) hypothesizes the presence of a little populace of diseased cells with characteristic properties like protection from traditional radio-chemotherapy regiments and increased metastatic potential. Clinically, the forceful idea of CSCs has been appeared to connect with expanded tumour repeat, metastatic spread, and generally very low patient result over various malignant growth subtypes. Separation of CSC’s has been achieved through the use of cell surface markers by the useful contrasts among CSCs and remaining tumour cells have been portrayed through expansion, separation, and constraining weakening measures.
- Track 1-1Embryonic Stem Cell
- Track 1-2Epigenetics
Oncology is a part of the medication that bargains with the anticipation, conclusion, and treatment of Cancer disease. Survival has been enhanced because of three primary segments including enhanced counteractive action endeavours to diminish presentation to chance elements (e.g., tobacco smoking and liquor utilization) enhanced screening of a few tumours (taking into consideration prior finding), and upgrades in treatment.
Malignant growths are regularly overseen through discourse on multi-disciplinary disease gatherings where radiation oncologists, pathologists, radiologists, and organ particular oncologists meet to locate the most ideal administration for an individual patient considering the physical, social, mental, and money related status of the patient. It is vital for oncologists to keep refreshed as for the most recent headways in oncology, as changes in administration of malignancy are very normal.
- Track 2-1Immuno Oncology
- Track 2-2Nursing Oncology
- Track 2-3Cancer Science
Cancer Oncology examines are being led remembering different classes or criteria like area, influenced organ, sort of Cancer disease, kind of consideration or drug, condition or encompassing.
- Track 3-1Medical oncology
- Track 3-2Radiation Oncology
- Track 3-3Surgical Oncology
Stem Cells are Biological cells that can separate into different sorts of cells and can divide to deliver same kind of cells in huge numbers. They are found in multicellular life forms. In mammals, there are two wide kinds of stem cells: embryonic stem cells, which are isolated from the internal cell mass of blastocysts, and adult stem cells, which are found in different tissues.
- Track 4-1 Neural Stem Cells
- Track 4-2tem cell in Organ Transplantation
- Track 4-3Tissue Regeneration
Liver cancer is the fifth most analysed and the second most ceaseless reason for cancer death in men around the world. Amongst liver cancers, hepatocellular carcinoma (HCC) represents the major histological subtype and it is one of the most common malignant human tumours. Research into the molecular biology of hepato-carcinogenesis has identified several biomarkers, which could provide additional information in order to better understand the biology of HCC. A large number of biomarkers have been shown to have probable predictive significance and a wide variety of molecular markers have been proven to be excellent diagnostic tools for HCC however it is hard to represent HCC with a single biomarker. Therefore, marks of a mix of biomarkers might be more important for the finding, arranging and visualization of HCC. Specifically, a correlation of HCC-CSCs phenotype to specific hepatic cancer subtypes and to specific clinical and pathological features has not yet been reported in human liver tumours.
- Track 5-1RAPD
- Track 5-2Transciptomic Biomarkers
- Track 5-3Proteomic Biomarkers
Immunology is a part of science that covers the study of immune systems in all living beings. Immunology outlines, measures, and contextualizes the physiological working of the immune system in conditions of both wellbeing and sicknesses; breakdowns of the immune system in immunological disorders , example : autoimmune diseases,, hypersensitivities immune deficiency, and rejection of transplants: the physical, compound and physiological attributes of the segments of the immune system in vitro, in situ, and in vivo. Immunology has applications in various orders of medication, especially in the fields of organ transplantation, oncology, rheumatology, virology, bacteriology, parasitology, psychiatry, and dermatology.
- Track 6-1Pluripotent Stem Cells
- Track 6-2Haemopoetic Stem Cell
- Track 6-3Mesenchymal Stem Cell
Cancer treatments against tumour, chemo-and radiotherapy, have various restrictions that prompt treatment disappointment and disease repeat. These cells are associated with tumour formation, support, metastasis and repeat. Consequently, with the end goal to create productive medicines that can prompt a dependable clinical reaction forestalling tumour backslide it is vital to create drugs that can particularly target and dispose of CSCs. On-going distinguishing proof of surface markers and comprehension of atomic element is related with CSC phenotype, assisted with the plan of viable medicines.
- Track 7-1Gene Treatment
- Track 7-2Epigenic Alternatives
- Track 7-3Radiation Treatments
Cancer types include Carcinoma, Sarcoma, tumours got from epithelial cells. This gathering incorporates a large number of the most widely recognized malignancies and incorporate almost each one of those in the bosom, prostate, lung, pancreas and colon.
- Track 8-1Bladder Cancer
- Track 8-2Breast Cancer
- Track 8-3Colon and Rectal Cancer
Cancer nanotechnology is a part of nanotechnology which deals with various techniques, equipment’s also known as Nano-materials to the analysis and treatment of cancer. It is the branch of nanotechnology that uses Nano-science and Nano vectors to cure or stop cancer cells and their growth
- Track 9-1Cancer Treatment
- Track 9-2Immunotherapy
- Track 9-3Nanotechnology in Cancer Cure
Organizing can be "clinical" or "neurotic." Clinical organizing is based on the after effects of the tests done prior to the medical procedure for example: physical examinations and imaging filters. Neurotic organizing based on what is found through the medical procedure. Clinical stage is regularly demonstrated by a lowercase "c" before the TNM grouping. The obsessive stage is demonstrated by a lowercase "p."
- Track 10-1TNM framework organizing
- Track 10-2Post Therapy
- Track 10-3Recurrence
There can be more than one reason for cancer cells formation and growth. Various powers can cause quality changes, for example, smoking, radiation, infections, Cancer causing synthetic compounds (cancer-causing agents), heftiness, hormones, endless aggravation and an absence of activity.
- Track 11-1Hereditary Malignancies
- Track 11-2Radiation effect
- Track 11-3Lifestyle effects
The causes for cancer may differ from genetic to the lifestyle of an individual. Cancer can spread from one region of the body to another and can also lead to death, there are some ways to treat or to reduce the spread of it.
- Track 12-1Chemotherapy
- Track 12-2Immunotherapy
- Track 12-3Hormonal Treatment
Cancer Prevention contains steps that are taken to bring down the danger of getting the Cancer disease. This can incorporate keeping up a solid way of life, to know disease causing substances, and taking prescriptions or immunizations that can keep cancer from formation.
- Track 13-1Proper and Healthy Diet
- Track 13-2Medication
- Track 13-3Change in Lifestyle
Clinical preliminaries are broadly observed for real advances in Cancer treatment because of developing new medications to avert or help oversee Graft-Versus-Host Disease (GvHD). Graft-Versus-Host Disease a typical and conceivably extreme reaction of stem cell transplants in which contributor safe cells attack solid patient cells and tissues. Creating cancer immunization systems for use alongside transplant to invigorate the Graft-Versus- leukaemia (GVL) impact and limit malady backslide. Graft-versus-Leukaemia has restorative impact in which transplanted invulnerable cells attack leftover leukaemia or other tumour cells
- Track 14-1Cellular therapy
- Track 14-2Tissue regeneration
- Track 14-3Drug discovery
MicroRNAs are a type of small non-coding RNA molecule that performs a vital role in post-transcriptional gene regulation. Since miRNAs were first identified in 1993, a number of studies have demonstrated that they act as tumor suppressors or oncogenes in human cancer, including colorectal, lung, brain, breast and liver cancer, and leukemia. Studies have previously revealed that miRNA profiling is important for the diagnosis and prognosis of patients with cancer, while certain miRNAs possess the potential to be used as diagnostic and prognostic biomarkers or therapeutic targets in cancer. Studies review and examines the roles of miRNAs in prognosis, cancer diagnosis and treatment, discusses the probable therapeutic modality of misusing miRNAs.